+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Amines 101711-55-1
101711-55-1,MFCD18206132
Catalog No.:AA00057O

101711-55-1 | 2-(tert-Butyldimethylsilyloxy)ethanamine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
95%
in stock  
$6.00   $4.00
- +
5g
95%
in stock  
$13.00   $9.00
- +
10g
95%
in stock  
$24.00   $17.00
- +
25g
95%
in stock  
$46.00   $32.00
- +
100g
95%
in stock  
$168.00   $117.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00057O
Chemical Name:
2-(tert-Butyldimethylsilyloxy)ethanamine
CAS Number:
101711-55-1
Molecular Formula:
C8H21NOSi
Molecular Weight:
175.3439
MDL Number:
MFCD18206132
SMILES:
NCCO[Si](C(C)(C)C)(C)C
Properties
Computed Properties
 
Complexity:
118  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
4  

Upstream Synthesis Route

[1]JournalofOrganicChemistry,2010,vol.75,#17,p.6023-6026

[2]Patent:WO2015/100363,2015,A1,.Locationinpatent:Page/Pagecolumn43

[3]Patent:US2014/194431,2014,A1,.Locationinpatent:Paragraph1044-1045

[4]AngewandteChemie-InternationalEdition,2014,vol.53,#42,p.11356-11360

[5]Angew.Chem.,2014,vol.126,#42,p.11538-11542,5

[6]Patent:US2010/16610,2010,A1,.Locationinpatent:Page/Pagecolumn40

[7]JournalofHeterocyclicChemistry,2011,vol.48,#3,p.533-539

[8]BioorganicandMedicinalChemistryLetters,2012,vol.22,#4,p.1722-1726

[9]Patent:WO2009/77741,2009,A2,.Locationinpatent:Page/Pagecolumn82

[10]TetrahedronLetters,2014,vol.55,#29,p.3957-3959

[11]Patent:EP1462452,2004,A1,.Locationinpatent:Page9-10

[12]Patent:WO2008/151304,2008,A1,.Locationinpatent:Page/Pagecolumn132

[13]BioconjugateChemistry,2010,vol.21,#8,p.1545-1553

[14]AdvancedSynthesisandCatalysis,2012,vol.354,#17,p.3187-3194

[15]Patent:WO2012/151512,2012,A2,.Locationinpatent:Page/Pagecolumn149-150

[16]ACSMedicinalChemistryLetters,2016,vol.7,#12,p.1139-1144

[17]Patent:WO2014/30142,2014,A2,.Locationinpatent:Page/Pagecolumn29;30

[18]Tetrahedron,2008,vol.64,#13,p.2938-2950

[19]Patent:WO2017/100154,2017,A1,.Locationinpatent:Paragraph00129

[20]OrganicLetters,2007,vol.9,#1,p.101-104

[21]ChineseChemicalLetters,2013,vol.24,#11,p.1019-1022

[22]ChemicalResearchinToxicology,2016,vol.29,#10,p.1706-1719

[23]JournaloftheAmericanChemicalSociety,2007,vol.129,#37,p.11408-11420

[24]Patent:WO2014/140076,2014,A1,.Locationinpatent:Page/Pagecolumn185

[25]Patent:WO2013/128421,2013,A1,.Locationinpatent:Page/Pagecolumn83

[26]Patent:WO2015/118554,2015,A1,.Locationinpatent:Page/Pagecolumn20;21

[27]Patent:WO2010/19511,2010,A2,.Locationinpatent:Page/Pagecolumn157

[28]Patent:WO2015/81282,2015,A1,.Locationinpatent:Paragraph00734;00735

[29]Patent:WO2015/187428,2015,A1,.Locationinpatent:Page/Pagecolumn00521;00522;00523

[30]JournaloftheChemicalSociety-PerkinTransactions1,1998,#4,p.651-660

[31]BioorganicandMedicinalChemistry,2005,vol.13,#11,p.3821-3839

[32]Patent:WO2007/70173,2007,A2,.Locationinpatent:Page/Pagecolumn47-48

[33]JournalofOrganicChemistry,2009,vol.74,#4,p.1791-1793

[34]BioorganicandMedicinalChemistryLetters,2009,vol.19,#5,p.1340-1343

[35]Patent:US2009/275606,2009,A1,.Locationinpatent:Page/Pagecolumn40-41

[36]ChemicalCommunications,2011,vol.47,#42,p.11712-11714

[37]Chemistry-AnAsianJournal,2012,vol.7,#5,p.911-914

[38]Patent:US2012/184542,2012,A1,.Locationinpatent:Page/Pagecolumn30

[39]Patent:WO2011/37610,2011,A1,.Locationinpatent:Page/Pagecolumn47

[40]BioorganicandMedicinalChemistry,2014,vol.22,#7,p.2123-2132

[41]JournalofOrganicChemistry,2015,vol.80,#18,p.9185-9191

[42]Patent:US9181281,2015,B2,.Locationinpatent:Page/Pagecolumn27;28

[43]OrganicLetters,2017,vol.19,#12,p.3235-3238

[44]Patent:WO2017/156181,2017,A1,.Locationinpatent:Paragraph00396

[45]Patent:WO2017/156179,2017,A1,.Locationinpatent:Paragraph00251;00252;00253

[1]JournalofMedicinalChemistry,2018,vol.61,#3,p.1241-1254

Downstream Synthesis Route
3112-31-0    101711-55-1   
3,5-bis2-(tert-butyldimethylsilyloxy)ethylcarbamoylpyrazole 

[1]Eisenwiener,Alexander;Neuburger,Markus;Kaden,ThomasA.[DaltonTransactions,2007,#2,p.218-233]

[1]Patent:WO2009/106419,2009,A1.Locationinpatent:Page/Pagecolumn79-80

[2]Patent:WO2008/17696,2008,A1.Locationinpatent:Page/Pagecolumn57

[1]Locationinpatent:experimentalpartNg,Pei-Sze;Laing,BrianM.;Balasundarum,Ganesan;Pingle,Maneesh;Friedman,Alan;Bergstrom,DonaldE.[BioconjugateChemistry,2010,vol.21,#8,p.1545-1553]

[1]CurrentPatentAssignee:ASTRAZENECAPLC-WO2011/121350,2011,A1Locationinpatent:Page/Pagecolumn143-144

[1]Patent:WO2014/9447,2014,A1.Locationinpatent:Page/Pagecolumn103

[2]Patent:WO2014/202741,2014,A1.Locationinpatent:Page/Pagecolumn47

[3]Patent:US2015/197529,2015,A1.Locationinpatent:Paragraph1221;1222

[4]Patent:US2016/168141,2016,A1.Locationinpatent:Paragraph1230;1231;1232

[5]Patent:WO2016/96936,2016,A1.Locationinpatent:Page/Pagecolumn47

[6]Patent:WO2017/5668,2017,A1.Locationinpatent:Page/Pagecolumn45

[7]Patent:WO2017/5900,2017,A1.Locationinpatent:Page/Pagecolumn74

[8]Patent:WO2017/102796,2017,A1.Locationinpatent:Page/Pagecolumn50;51

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 101711-55-1
204580-28-9

204580-28-9

 175717-75-6

175717-75-6

 175717-73-4

175717-73-4

 117460-98-7

117460-98-7

 117460-98-7

117460-98-7
Building Blocks
More >
Tags:101711-55-1 Molecular Formula|101711-55-1 MDL|101711-55-1 SMILES|101711-55-1 2-(tert-Butyldimethylsilyloxy)ethanamine